CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
46 hedge funds and large institutions have $18.8M invested in Carisma Therapeutics in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.29% less ownership
Funds ownership: 1.15% → 0.86% (-0.29%)
31% less capital invested
Capital invested by funds: $27.3M → $18.8M (-$8.59M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
46
Holding in Top 10
1
Calls
$1.74M
Puts
$219K
Top Buyers
| 1 | +$1.35M | |
| 2 | +$647K | |
| 3 | +$395K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$261K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$261K |
Top Sellers
| 1 | -$5.54M | |
| 2 | -$4.48M | |
| 3 | -$167K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$114K |
| 5 |
MTIM
Marathon Trading Investment Management
Radnor,
Pennsylvania
|
-$39.4K |